222 followers
A multicenter, non-randomized, phase II study of docetaxel and carboplatin administered every 3 weeks as second… http://t.co/iufqgtT7fC
A multicenter, non-randomized, phase II study of docetaxel and carboplatin administered every 3 weeks as second… http://t.co/iufqgtT7fC